← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 1991First marketed drug
Jan 1, 1927First NDA
Jun 1, 1940Last known activity
Jan 1, 2000
Acquired by Warner Lambert → Pfizer on Dec 31, 1970
Timeline
1860s
- Jan 1, 1867
Parke-Davis— Founded
1950s
- Jun 1, 1951
chloramphenicol— NDA Secondary Org
1970s
- Dec 31, 1970
Warner Lambert— Acquired By
- Aug 27, 1976
phenytoin— Marketing Organization
1990s
- Apr 26, 1996
quinestrol— NDA Organization
2000s
- Jan 1, 2000
Pfizer— Now
Drugs by trial phase (10 distinct, 8 trials)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Approved for
- Acne Vulgaris
- Amebiasis
- Amenorrhea
- Anxiety
- Arthritis, Juvenile
- Arthritis, Rheumatoid
- Depression
- Dysmenorrhea
- Endometriosis
- Enterobiasis
- Epilepsy
- Epilepsy, Absence
- Heart Failure
- Hepatic Encephalopathy
- Hypersensitivity
- Hypogonadism
- Malaria
- Menorrhagia
- Mutism
- Obesity
- Osteoarthritis
- Pain
- Pregnancy
- Rhinitis, Allergic, Seasonal
- Seizures
- Sleep Initiation and Maintenance Disorders
- Status Epilepticus
- Uterine Hemorrhage
- Vascular Headaches
Marketed drugs (68)
Recent trials (9)
- NCT00492037CollaboratorPhase 3Jan 1, 2000
- NCT00600106CollaboratorN/ADec 31, 1999
- NCT00600106OfficialN/ADec 31, 1999
- NCT00002218Lead sponsorPhase 1Nov 2, 1999
- NCT00002196Lead sponsorPhase 1Nov 2, 1999
- NCT00007670CollaboratorPhase 3Jan 1, 1998
- NCT00005624CollaboratorPhase 2Aug 1, 1997
- NCT00116545Lead sponsorPhase 2/Phase 3Jan 1, 1997
- NCT00283335CollaboratorPhase 3Jun 1, 1991
Details
- Founded
- Detroit, MI, US Jan 1, 1867
- First NDA
- Jun 1, 1940
- Last known activity
- Jan 1, 2000
Designations held
- Orphan drug
- Priority review